Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

7.170 -0.010 (-0.14%)
Streaming Delayed Price Updated: 11:13 AM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtaiBeckley Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
News headline image
Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock ↗
Lilly's pipeline is on track to pick up a handful of interesting new programs. 
Via The Motley Fool
News headline image
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. ↗
Cathie Wood is loading up on shares of a biotech that could be one of the first entrants to the psychedelics market. 
Via The Motley Fool
Topics ETFs Government
News headline image
Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs ↗
The company isn't resting on its laurels. 
Via The Motley Fool
News headline image
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗
Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline. 
Via The Motley Fool
News headline image
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:CMPS),(NASDAQ:ATAI),(NYSE:JNJ),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Unusual volume stocks in Monday's session ↗
Via Chartmill
News headline image
AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Why AtaiBeckley Stock Soared Today ↗
The psychedelic drugmaker is being acquired. 
Via The Motley Fool
News headline image
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion ↗
Today, July 16, 2026, the clinical-stage psychedelics developer jumped 33% after Lilly announced a cash deal plus milestone payments. 
Via The Motley Fool
Topics Government Stocks
What's going on in today's session ↗
Via Chartmill
Curious about the most active stocks on Thursday? ↗
Via Chartmill
News headline image
Power Movers: PRSO, ATAI, IQST, TGHL Watch Now
Via AB Newswire
Topics Artificial Intelligence Economy
Thursday's session: top gainers and losers ↗
Via Chartmill
News headline image
Halper Sadeh LLC is Investigating Whether ATAI, CCRN, NUVL are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether AtaiBeckley Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session. The market value of their outstanding shares is at $1.9 billion. Agape ATP (NASDAQ:ATPC) shares moved... 
Via Benzinga
News headline image
What This $496,000 Insider Sale at AtaiBeckley Means Amid Roughly 100% Stock Run ↗
Hershberg exercised vested options and liquidated them under a Rule 10b5-1 plan, halving direct equity while retaining 404,869 derivative securities. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
AtaiBeckley to Join the Russell Indexes, Expanding Visibility Across U.S. Equity Markets
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
From AtaiBeckley Inc.
Via GlobeNewswire
News headline image
These 3 Psychedelic Stocks Activated After Trump's Executive Order ↗
Via MarketBeat
Topics Government
News headline image
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research
From AtaiBeckley Inc.
Via GlobeNewswire
After Fifteen Years, Tim Cook Steps Down, Wall Street Steps Back, Oil Steps Up ↗
Via Chartmill
News headline image
Why AtaiBeckley Stock Surged Today ↗
President Trump wants to fast-track psychedelic research. 
Via The Motley Fool
Topics Government
News headline image
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
Via AB Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.